Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021
The global breast imaging market is estimated to grow at a CAGR of 8.5% from 2016 to 2021. Although developed regions (such as North America and Europe) held large shares in the breast imaging market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 9.5% in the next five years. Factors such as the rising patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending in emerging APAC countries on breast cancer research studies, and implementation of several initiatives to create awareness about the early detection of breast cancer are driving the growth of the breast imaging market in this region.
The growth of the global breast imaging market is driven by factors such as the rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. In addition, increasing demand for breast imaging in emerging Asian countries and technological innovation in breast cancer detection are expected to offer growth opportunities to market players. However, a number of factors such as the high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are expected to restrain the growth of the breast imaging market. Besides, stringent regulatory approval procedures and unfavorable reimbursement scenario in developing countries will further restrain the growth of this market in the coming years.
In this report, the breast imaging market has been segmented on the basis of type [covering ionizing breast imaging technologies (analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography) and non-ionizing breast imaging technologies (including breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, and optical imaging)]; and region [North America (U.S., and Canada), Europe (Germany, France, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World]. The ionizing breast imaging technologies segment is estimated to account for the larger share of the global breast imaging market in 2016. However, the non-ionizing breast imaging technologies segment is expected to grow at the highest CAGR during the forecast period. The advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as lower risk of radiation exposure, greater anatomical details for diagnosis, higher sensitivity to small breast lesions in women with dense breast tissues, and lower false positives are driving the growth of this market segment.
Geographically, North America is estimated to command the largest share of 43.8% of the global breast imaging market in 2016, followed by Europe. The large share of the North American region is attributed to the widespread adoption of newer techniques, such as 3D breast tomosythesis, breast MRI, molecular breast imaging, and automated whole-breast ultrasound (AWBU). A number of factors, such as the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses are further stimulating the growth of the breast imaging market in North America. However, high cost of breast screening and limited availability of some radioactive isotopes are negatively affecting the growth of the breast imaging market in this region.
Hologic, Inc. (U.S.), GE Healthcare (U.K.), and Siemens Healthcare (Germany) were the top three players in the breast imaging market in 2015. These companies together accounted for 74.0% of the global market. Product launches, upgrades, and approvals; and partnerships, agreements, and collaborations are the major strategies adopted by most market players to achieve growth in the breast imaging market.
Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis— market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the breast imaging market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
The growth of the global breast imaging market is driven by factors such as the rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. In addition, increasing demand for breast imaging in emerging Asian countries and technological innovation in breast cancer detection are expected to offer growth opportunities to market players. However, a number of factors such as the high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are expected to restrain the growth of the breast imaging market. Besides, stringent regulatory approval procedures and unfavorable reimbursement scenario in developing countries will further restrain the growth of this market in the coming years.
In this report, the breast imaging market has been segmented on the basis of type [covering ionizing breast imaging technologies (analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography) and non-ionizing breast imaging technologies (including breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, and optical imaging)]; and region [North America (U.S., and Canada), Europe (Germany, France, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World]. The ionizing breast imaging technologies segment is estimated to account for the larger share of the global breast imaging market in 2016. However, the non-ionizing breast imaging technologies segment is expected to grow at the highest CAGR during the forecast period. The advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as lower risk of radiation exposure, greater anatomical details for diagnosis, higher sensitivity to small breast lesions in women with dense breast tissues, and lower false positives are driving the growth of this market segment.
Geographically, North America is estimated to command the largest share of 43.8% of the global breast imaging market in 2016, followed by Europe. The large share of the North American region is attributed to the widespread adoption of newer techniques, such as 3D breast tomosythesis, breast MRI, molecular breast imaging, and automated whole-breast ultrasound (AWBU). A number of factors, such as the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses are further stimulating the growth of the breast imaging market in North America. However, high cost of breast screening and limited availability of some radioactive isotopes are negatively affecting the growth of the breast imaging market in this region.
Hologic, Inc. (U.S.), GE Healthcare (U.K.), and Siemens Healthcare (Germany) were the top three players in the breast imaging market in 2015. These companies together accounted for 74.0% of the global market. Product launches, upgrades, and approvals; and partnerships, agreements, and collaborations are the major strategies adopted by most market players to achieve growth in the breast imaging market.
Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis— market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the breast imaging market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on breast imaging offered by the top 10 players in the breast imaging market. The report analyzes the breast imaging market by type across four geographies
- Product Development/Innovation: Detailed insights on current technologies, research and development activities, and new product launches in the breast imaging market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various breast imaging products across four geographies (North America, Europe, Asia-Pacific, and Rest of the World)
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1.1 Bottom-up approach
2.2.1.2 Top-down approach
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 BREAST IMAGING MARKET OVERVIEW
4.2 BREAST IMAGING MARKET SHARE, BY TYPE, 2016 VS. 2021
4.3 GEOGRAPHIC ANALYSIS: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE
4.4 GEOGRAPHIC ANALYSIS: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE (2016)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 MARKET SEGMENTATION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of breast cancer
5.2.1.2 Government investments and funding for breast cancer treatment and related research
5.2.1.3 Increasing awareness about early detection of breast cancer
5.2.1.4 Rapidly increasing aging population
5.2.1.5 Technological advancements in breast imaging modalities
5.2.1.6 Launch of advanced systems capable of detecting cancer in women with dense breast tissue
5.2.2 RESTRAINTS
5.2.2.1 High installation costs of breast imaging systems
5.2.2.2 Side effects of radiation exposure
5.2.2.3 Errors in breast cancer screening and diagnosis
5.2.2.4 Stringent regulatory approval procedures
5.2.2.5 Unfavorable reimbursement scenario in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies offer high growth potential
5.2.3.2 Technological innovations in breast cancer detection
6 BREAST IMAGING MARKET, BY TYPE
6.1 INTRODUCTION
6.2 IONIZING BREAST IMAGING TECHNOLOGIES
6.2.1 FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM)
6.2.2 ANALOG MAMMOGRAPHY
6.2.3 3D BREAST TOMOSYNTHESIS
6.2.4 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)
6.2.5 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)
6.2.6 CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)
6.2.7 POSITRON EMISSION MAMMOGRAPHY (PEM)
6.2.8 ELECTRIC IMPEDANCE TOMOGRAPHY
6.3 NON-IONIZING BREAST IMAGING TECHNOLOGIES
6.3.1 BREAST ULTRASOUND
6.3.2 BREAST MRI
6.3.3 AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)
6.3.4 BREAST THERMOGRAPHY
6.3.5 OPTICAL IMAGING
7 BREAST IMAGING MARKET, BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 U.K.
7.3.4 REST OF EUROPE
7.4 ASIA-PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD (ROW)
8 COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 STRATEGIC OVERVIEW
8.3 MARKET SHARE ANALYSIS
8.4 COMPETITIVE SITUATION AND TRENDS
8.4.1 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS
8.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
8.4.3 OTHER DEVELOPMENTS
9 COMPANY PROFILE
9.1 INTRODUCTION
9.2 HOLOGIC, INC.
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS OFFERED
9.2.3 RECENT DEVELOPMENTS
9.2.4 MNM VIEW
9.3 GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS OFFERED
9.3.3 RECENT DEVELOPMENTS
9.3.4 MNM VIEW
9.4 SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS OFFERED
9.4.3 RECENT DEVELOPMENTS
9.4.4 MNM VIEW
9.5 PHILIPS HEALTHCARE (A PART OF KONINKLIJKE PHILIPS N.V.)
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS OFFERED
9.5.3 RECENT DEVELOPMENTS
9.5.4 MNM VIEW
9.6 FUJIFILM HOLDINGS CORPORATION
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS OFFERED
9.6.3 RECENT DEVELOPMENTS
9.6.4 MNM VIEW
9.7 GAMMA MEDICA, INC.
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS OFFERED
9.7.3 RECENT DEVELOPMENTS
9.8 TOSHIBA CORPORATION
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS OFFERED
9.8.3 RECENT DEVELOPMENTS
9.9 SONOCIN?, INC.
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS OFFERED
9.9.3 RECENT DEVELOPMENTS
9.10 AURORA IMAGING TECHNOLOGY, INC.
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS OFFERED
9.11 DILON TECHNOLOGIES, INC.
9.11.1 BUSINESS OVERVIEW
9.11.2 PRODUCTS OFFERED
9.11.3 RECENT DEVELOPMENTS
10 APPENDIX
10.1 DISCUSSION GUIDE*
10.2 ADDITIONAL DEVELOPMENTS
10.2.1 HOLOGIC, INC.
10.2.2 GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
10.2.3 PHILIPS HEALTHCARE (A PART OF KONINKLIJKE PHILIPS N.V.)
10.2.4 SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
10.2.5 GAMMA MEDICA, INC
10.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
10.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.5 AVAILABLE CUSTOMIZATIONS
10.6 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1.1 Bottom-up approach
2.2.1.2 Top-down approach
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 BREAST IMAGING MARKET OVERVIEW
4.2 BREAST IMAGING MARKET SHARE, BY TYPE, 2016 VS. 2021
4.3 GEOGRAPHIC ANALYSIS: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE
4.4 GEOGRAPHIC ANALYSIS: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE (2016)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 MARKET SEGMENTATION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of breast cancer
5.2.1.2 Government investments and funding for breast cancer treatment and related research
5.2.1.3 Increasing awareness about early detection of breast cancer
5.2.1.4 Rapidly increasing aging population
5.2.1.5 Technological advancements in breast imaging modalities
5.2.1.6 Launch of advanced systems capable of detecting cancer in women with dense breast tissue
5.2.2 RESTRAINTS
5.2.2.1 High installation costs of breast imaging systems
5.2.2.2 Side effects of radiation exposure
5.2.2.3 Errors in breast cancer screening and diagnosis
5.2.2.4 Stringent regulatory approval procedures
5.2.2.5 Unfavorable reimbursement scenario in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies offer high growth potential
5.2.3.2 Technological innovations in breast cancer detection
6 BREAST IMAGING MARKET, BY TYPE
6.1 INTRODUCTION
6.2 IONIZING BREAST IMAGING TECHNOLOGIES
6.2.1 FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM)
6.2.2 ANALOG MAMMOGRAPHY
6.2.3 3D BREAST TOMOSYNTHESIS
6.2.4 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)
6.2.5 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)
6.2.6 CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)
6.2.7 POSITRON EMISSION MAMMOGRAPHY (PEM)
6.2.8 ELECTRIC IMPEDANCE TOMOGRAPHY
6.3 NON-IONIZING BREAST IMAGING TECHNOLOGIES
6.3.1 BREAST ULTRASOUND
6.3.2 BREAST MRI
6.3.3 AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)
6.3.4 BREAST THERMOGRAPHY
6.3.5 OPTICAL IMAGING
7 BREAST IMAGING MARKET, BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 U.K.
7.3.4 REST OF EUROPE
7.4 ASIA-PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD (ROW)
8 COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 STRATEGIC OVERVIEW
8.3 MARKET SHARE ANALYSIS
8.4 COMPETITIVE SITUATION AND TRENDS
8.4.1 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS
8.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
8.4.3 OTHER DEVELOPMENTS
9 COMPANY PROFILE
9.1 INTRODUCTION
9.2 HOLOGIC, INC.
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS OFFERED
9.2.3 RECENT DEVELOPMENTS
9.2.4 MNM VIEW
9.3 GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS OFFERED
9.3.3 RECENT DEVELOPMENTS
9.3.4 MNM VIEW
9.4 SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS OFFERED
9.4.3 RECENT DEVELOPMENTS
9.4.4 MNM VIEW
9.5 PHILIPS HEALTHCARE (A PART OF KONINKLIJKE PHILIPS N.V.)
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS OFFERED
9.5.3 RECENT DEVELOPMENTS
9.5.4 MNM VIEW
9.6 FUJIFILM HOLDINGS CORPORATION
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS OFFERED
9.6.3 RECENT DEVELOPMENTS
9.6.4 MNM VIEW
9.7 GAMMA MEDICA, INC.
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS OFFERED
9.7.3 RECENT DEVELOPMENTS
9.8 TOSHIBA CORPORATION
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS OFFERED
9.8.3 RECENT DEVELOPMENTS
9.9 SONOCIN?, INC.
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS OFFERED
9.9.3 RECENT DEVELOPMENTS
9.10 AURORA IMAGING TECHNOLOGY, INC.
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS OFFERED
9.11 DILON TECHNOLOGIES, INC.
9.11.1 BUSINESS OVERVIEW
9.11.2 PRODUCTS OFFERED
9.11.3 RECENT DEVELOPMENTS
10 APPENDIX
10.1 DISCUSSION GUIDE*
10.2 ADDITIONAL DEVELOPMENTS
10.2.1 HOLOGIC, INC.
10.2.2 GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
10.2.3 PHILIPS HEALTHCARE (A PART OF KONINKLIJKE PHILIPS N.V.)
10.2.4 SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
10.2.5 GAMMA MEDICA, INC
10.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
10.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.5 AVAILABLE CUSTOMIZATIONS
10.6 RELATED REPORTS
LIST OF TABLES
Table 1 GROWING PREVALENCE OF BREAST CANCER TO TRIGGER MARKET GROWTH
Table 2 HIGH INSTALLATION COSTS OF BREAST IMAGING SYSTEMS TO RESTRAIN MARKET GROWTH
Table 3 EMERGING MARKETS OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET PLAYERS
Table 4 BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 5 IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 6 GLOBAL FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 7 NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 8 EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 9 ASIA-PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 10 GLOBAL ANALOG MAMMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 12 EUROPE: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 ASIA-PACIFIC: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 14 GLOBAL 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 16 EUROPE: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 17 ASIA-PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 18 GLOBAL POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 20 EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 21 ASIA-PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 22 GLOBAL MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 24 EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 25 ASIA-PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 26 GLOBAL CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 28 EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 29 ASIA-PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 30 GLOBAL POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 31 NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 32 EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 33 ASIA-PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 34 GLOBAL ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 36 EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 37 ASIA-PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 38 NON-IONIZING BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 39 GLOBAL BREAST ULTRASOUND MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 40 NORTH AMERICA: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 41 EUROPE: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 42 ASIA-PACIFIC: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 43 GLOBAL BREAST MRI MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 44 NORTH AMERICA: BREAST MRI MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 45 EUROPE: BREAST MRI MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 46 ASIA-PACIFIC: BREAST MRI MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 47 GLOBAL AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 48 NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 49 EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 50 ASIA-PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 51 GLOBAL BREAST THERMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 52 NORTH AMERICA: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 53 EUROPE: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 54 ASIA-PACIFIC: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 55 GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 56 NORTH AMERICA: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 57 EUROPE: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 58 ASIA-PACIFIC: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 59 BREAST IMAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 60 NORTH AMERICA: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 61 NORTH AMERICA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 62 NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 63 NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 64 U.S.: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 65 U.S.: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE 2014–2021 (USD MILLION)
Table 66 U.S.: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 67 CANADA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 68 CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 69 CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 70 EUROPE: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 71 EUROPE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 72 EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 73 EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 GERMANY: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 75 GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 76 GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 FRANCE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 79 FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 80 U.K.: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 81 U.K.: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 82 U.K.: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 83 REST OF EUROPE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 84 REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 85 REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 86 ASIA-PACIFIC: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 87 ASIA-PACIFIC: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 88 ASIA-PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 89 ASIA-PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 90 JAPAN: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 91 JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 92 JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 93 CHINA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 94 CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2016-2021 (USD MILLION)
Table 95 CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 96 INDIA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 97 INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 98 INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 99 ROAPAC: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 100 ROAPAC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 101 ROAPAC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 102 ROW: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 103 ROW: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 104 ROW: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 105 TOP 5 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, 2013–2016
Table 106 TOP 5 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2013–2016
Table 107 TOP 5 OTHER DEVELOPMENTS, 2013–2016
Table 1 GROWING PREVALENCE OF BREAST CANCER TO TRIGGER MARKET GROWTH
Table 2 HIGH INSTALLATION COSTS OF BREAST IMAGING SYSTEMS TO RESTRAIN MARKET GROWTH
Table 3 EMERGING MARKETS OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET PLAYERS
Table 4 BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 5 IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 6 GLOBAL FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 7 NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 8 EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 9 ASIA-PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 10 GLOBAL ANALOG MAMMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 12 EUROPE: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 ASIA-PACIFIC: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 14 GLOBAL 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 16 EUROPE: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 17 ASIA-PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 18 GLOBAL POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 20 EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 21 ASIA-PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 22 GLOBAL MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 24 EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 25 ASIA-PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 26 GLOBAL CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 28 EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 29 ASIA-PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 30 GLOBAL POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 31 NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 32 EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 33 ASIA-PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 34 GLOBAL ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 36 EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 37 ASIA-PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 38 NON-IONIZING BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 39 GLOBAL BREAST ULTRASOUND MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 40 NORTH AMERICA: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 41 EUROPE: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 42 ASIA-PACIFIC: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 43 GLOBAL BREAST MRI MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 44 NORTH AMERICA: BREAST MRI MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 45 EUROPE: BREAST MRI MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 46 ASIA-PACIFIC: BREAST MRI MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 47 GLOBAL AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 48 NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 49 EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 50 ASIA-PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 51 GLOBAL BREAST THERMOGRAPHY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 52 NORTH AMERICA: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 53 EUROPE: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 54 ASIA-PACIFIC: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 55 GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 56 NORTH AMERICA: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 57 EUROPE: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 58 ASIA-PACIFIC: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 59 BREAST IMAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 60 NORTH AMERICA: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 61 NORTH AMERICA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 62 NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 63 NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 64 U.S.: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 65 U.S.: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE 2014–2021 (USD MILLION)
Table 66 U.S.: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 67 CANADA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 68 CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 69 CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 70 EUROPE: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 71 EUROPE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 72 EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 73 EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 GERMANY: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 75 GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 76 GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 FRANCE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 79 FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 80 U.K.: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 81 U.K.: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 82 U.K.: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 83 REST OF EUROPE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 84 REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 85 REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 86 ASIA-PACIFIC: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table 87 ASIA-PACIFIC: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 88 ASIA-PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 89 ASIA-PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 90 JAPAN: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 91 JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 92 JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 93 CHINA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 94 CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2016-2021 (USD MILLION)
Table 95 CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 96 INDIA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 97 INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 98 INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 99 ROAPAC: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 100 ROAPAC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 101 ROAPAC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 102 ROW: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 103 ROW: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 104 ROW: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 105 TOP 5 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, 2013–2016
Table 106 TOP 5 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2013–2016
Table 107 TOP 5 OTHER DEVELOPMENTS, 2013–2016
The global breast imaging market is estimated to grow at a CAGR of 8.1% in the forecast period. Global rise in the incidences and prevalence of breast cancer cases, rapid growth in aging population, development of advanced breast imaging technologies, and increasing awareness about early breast cancer screening are some of the key factors that are fueling the growth of the market. However, side effects of radiation dosage during breast imaging procedures, high installation cost of this systems, and false cancer diagnosis are some of the key factors hampering the growth of this market. Furthermore, stringent regulatory approvals for new technologies and government pressure to reduce the usage of radiation dose are some of the key challenges faced by market players.
The emerging markets including China and India have become attractive for companies engaged in the development and marketing of the breast imaging technologies. Rising breast cancer awareness, government initiatives to increasing awareness about women healthcare, rising incidences of breast cancer, and increasing government investments in this technologies are the key factors propelling the demand of the this technologies in the emerging markets.
In 2013, Hologic, Inc. (U.S.) held the leading position in the global mammography market. Over the past three years, the company adopted expansion of its R&D capabilities, new product launches, and strategic partnerships/agreements as its key business strategies to ensure its dominant position in this market. In addition, GE Healthcare (U.K.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan) are some other key players in the global mammography market.
